Deerfield Management Company L.P. Series C Makes New $127,00

Deerfield Management Company L.P. Series C Makes New $127,000 Investment in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW)

Deerfield Management Company L.P. Series C bought a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 333,333 shares of the company’s stock, valued at approximately $127,000. Separately, Context Capital Management LLC acquired a new position in […]

Related Keywords

, Trisalus Life Sciences Inc , Quarter For Trisalus Life Sciences , News Ratings For Trisalus Life Sciences Daily , Nasdaq , Trisalus Life Sciences , Deerfield Management Companylp Series , Context Capital Management , Trisalus Life Sciences Stock Performance , Free Report , Salus Life Sciences , Trinav Infusion System , Pancreatic Retrograde Venous Infusion System , Trisalus Life Sciences Daily ,

© 2024 Vimarsana